COVID-19 is one of the most common triggers of telogen effluvium documented in recent years. Telogen effluvium is a form of temporary, diffuse hair shedding that happens when a physiological shock pushes an unusually large number of hair follicles out of their growth phase and into the resting (telogen) phase simultaneously. A large meta-analysis found that hair loss ranks among the top five symptoms with the highest relative risk in people who have had COVID-19, roughly 2.4 times more likely than in uninfected controls.1Nature Communications. The risk of Long Covid symptoms: a systematic review and meta-analysis of controlled studies The shedding typically starts weeks to months after the infection, and for most people it resolves on its own, but the experience can be alarming and psychologically distressing.
When Hair Loss Typically Starts
Hair follicles that are pushed prematurely into the resting phase do not fall out right away. They sit in telogen for roughly two to three months before detaching. That built-in delay is why you might feel perfectly recovered from COVID-19 and then suddenly notice clumps of hair in the shower drain or on your pillow. In one study of patients who developed hair loss after a confirmed COVID-19 infection, all of them reported the onset of excessive shedding within two to three months after infection.2PubMed Central. COVID-19 infection is a major cause of acute telogen effluvium – Section: Results Some clinicians have noted that this latency period after COVID-19 can be slightly shorter than the lag that follows other febrile illnesses, though the typical two-to-three-month window remains the most commonly reported range.3Thieme. COVID-19 Infection: Impact on Hair
The shedding itself can last anywhere from a few weeks to several months. In most cases the worst of it subsides within six months, but a subset of people experience persistent hair loss that continues well beyond that point. One clinical study specifically enrolled women whose COVID-related shedding had lasted more than six months.4PubMed. Efficacy of QR678 Neo(®) hair growth factor formulation for the treatment of hair loss in Covid-19-induced persistent Telogen Effluvium That kind of prolonged course is not the norm, but it is not rare enough to ignore.
How Common It Is After COVID-19
Estimates of how many COVID-19 patients go on to develop noticeable hair shedding vary depending on who was studied and how hair loss was measured. In one observational study of 198 hospitalized patients, about a quarter reported hair loss after discharge.5PubMed Central. Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity A cross-sectional study that surveyed 500 women who had been infected found that about 61 percent reported some kind of hair problem afterward, with telogen effluvium accounting for the majority of those cases.6PubMed Central. Hair disorders associated with post-COVID-19 infection in females – Section: Results That 61 percent figure is notably high, but it comes from self-reported data among women, who tend to notice and report hair changes more often than men. In the same study, about 30 percent said their hair problems started only after COVID-19, while the majority said existing shedding got worse.
When pooled across controlled studies using uninfected comparison groups, the picture is more conservative but still striking. The meta-analysis mentioned earlier found that hair loss carried a relative risk of about 2.4 compared to people who had not been infected.7Nature Communications. The risk of Long Covid symptoms: a systematic review and meta-analysis of controlled studies That puts hair loss on par with cognitive symptoms like poor concentration and impaired memory in terms of how much more frequently it appears in COVID-19 survivors. It ranks just behind the loss of smell and taste, which are the two most elevated long COVID symptoms.
Why COVID-19 Triggers Hair Loss
Telogen effluvium can follow any major stressor on the body, from high fevers to surgery to severe emotional distress. COVID-19 appears to hit the hair follicle through several routes at once, which may explain why the shedding is so widespread among survivors.
The most straightforward pathway is systemic inflammation. COVID-19 provokes an aggressive immune response, and the resulting surge of pro-inflammatory signaling molecules disrupts the normal growth cycle of the hair follicle.8PubMed Central. Covid Induced Telogen Effluvium (CITE): An Insight When the body is fighting a serious infection, it essentially deprioritizes non-essential functions like hair growth. The follicle gets the signal to shut down and enters its resting phase early.
On top of the general inflammatory hit, there is growing evidence that the virus may directly target hair follicle cells. A 2025 study found that when human hair follicles were exposed to SARS-CoV-2 in a lab setting, the viral protein accumulated in specific stem and progenitor cells in the outer root sheath of the follicle. Those infected cells showed signs of programmed cell death.9PubMed Central. Ex vivo detection of SARS CoV 2 spike protein in human hair follicles and potential link to telogen effluvium If this happens during a real infection, it would mean the virus is not just causing collateral damage through inflammation but actively harming the cells that maintain the hair cycle. This finding is still early-stage and has only been demonstrated outside the body, but it opens a potential explanation for why COVID-19 seems to cause more hair loss than many other respiratory illnesses.
A third mechanism involves the stress hormone axis. Severe illness floods the body with cortisol and other stress hormones, which interfere with follicular stem cell activity and disrupt the metabolism of proteins that follicles need to stay in the growth phase.10Regenerative Therapy. Systematic review: Impact of stem cells-based therapy, and platelet-rich plasma in hair loss and telogen effluvium related to COVID-19 – Section: Discussion COVID-19 also causes microvascular damage and tiny blood clots in some patients, which can reduce blood supply to the hair follicle. These microthrombi are considered another contributing factor, particularly in people who had more severe disease.11PubMed Central. Covid Induced Telogen Effluvium (CITE): An Insight
Who Is Most at Risk
Not everyone who catches COVID-19 sheds hair afterward, and certain factors seem to raise the odds substantially. Hospitalization, respiratory difficulties, significant weight loss during the illness, and a symptom duration longer than 10 days were all linked to more severe post-COVID hair loss in one large observational study.12International Journal of Dermatology and Venereology. Self-Reported Hair Loss Following COVID-19: An Observational Study – Section: Results Similarly, patients who required ICU admission or had severe shortness of breath were significantly more likely to develop hair problems afterward.13PubMed Central. Hair disorders associated with post-COVID-19 infection in females – Section: Results
Women are disproportionately represented in post-COVID hair loss studies, though this likely reflects a combination of genuine biological susceptibility and reporting patterns. In the study of 198 hospitalized patients, women made up about 60 percent of the total group but were overrepresented among those with hair loss.14PubMed Central. Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity Women are also more likely to have pre-existing iron deficiency, which matters because low ferritin levels appear to make post-COVID shedding worse.
The Iron Connection and Nutritional Factors
One of the more actionable findings from post-COVID hair loss research involves ferritin, the protein that stores iron. In a case-control study comparing COVID-19 survivors who developed telogen effluvium to those who did not, ferritin levels were significantly lower in the hair-loss group. The average ferritin in the shedding group was about half that of the controls.15PubMed Central. Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements – Section: Results Low iron stores are a well-known contributor to hair shedding in general, and a COVID-19 infection that deplete iron reserves through inflammation and reduced appetite can push the follicle over the edge.
The same study found something interesting about supplementation timing. Patients who had taken vitamin C, vitamin D, zinc, and lactoferrin during their COVID-19 illness were less likely to develop telogen effluvium afterward, while those who had not taken these supplements were more likely to shed.16PubMed Central. Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements – Section: Results This does not prove that popping a multivitamin will prevent hair loss, but it does suggest that nutritional support during and after infection may matter, especially for people who already have marginal iron or vitamin D levels.
Scalp Pain and Other Accompanying Symptoms
You might assume that hair shedding would be painless, but a surprising number of COVID-19 patients who develop telogen effluvium also experience trichodynia, a clinical term for an unpleasant, burning, or prickling sensation on the scalp. In one expert survey of dermatologists treating post-COVID patients, trichodynia appeared in about 58 percent of cases, and more than 40 percent of those patients had it alongside telogen effluvium.17PubMed Central. Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management – Section: Results Other studies report lower rates of scalp discomfort. A hospital-based study found trichodynia in about 16 percent and scalp itch in about 11 percent of post-COVID shedding patients.18PubMed Central. A Cross-Sectional Study on Post-Coronavirus Disease (COVID-19) Hair Loss at a Tertiary Care Hospital – Section: Results
Why the scalp hurts during shedding is not entirely understood, but it may involve the same inflammatory signaling that triggers the follicle transition. Neurogenic inflammation around the hair follicle can stimulate pain receptors in the scalp. If you are experiencing scalp tenderness alongside increased shedding, that combination actually fits the post-COVID pattern and is worth mentioning to a dermatologist, who can rule out other conditions.
The Psychological Toll
Losing hair after COVID-19 hits harder emotionally than most people expect. The shedding is often sudden and dramatic, and it comes on top of everything else the pandemic threw at people. The illness itself, the isolation, the financial stress, the general anxiety of living through a health crisis all feed into a cycle where the psychological distress of hair loss becomes a stressor that can itself perpetuate telogen effluvium.19Wiley Online Library. Management of telogen effluvium during the COVID-19 emergency: Psychological implications This feedback loop is real and well-recognized by dermatologists: stress causes shedding, shedding causes stress, and the cycle reinforces itself.
Understanding that post-COVID shedding is temporary and almost always reversible is genuinely therapeutic. Patient education about the natural timeline of telogen effluvium, and reassurance that the follicles themselves are not permanently damaged, can reduce anxiety and help interrupt the stress-shedding loop. If the emotional impact is severe, some clinicians recommend concurrent psychological support.
Can Vaccination Trigger Shedding Too?
There have been reports of hair shedding following COVID-19 vaccination, though the evidence is much thinner than for the infection itself. A Saudi Arabian survey of nearly 1,000 vaccinated individuals found that about 68 percent reported some degree of hair fall, but when the likely cause was investigated, less than 28 percent of those cases were attributed specifically to the vaccine, with nearly half attributed to other causes and another half classified as unclear.20PubMed Central. Telogen effluvium after COVID-19 vaccination among public in Saudi Arabia – Section: Results Self-reported surveys like this are tricky because people who are sensitized to hair loss during a pandemic may attribute normal shedding to whatever recent medical event they can identify.
Case reports do exist. A case series from Ecuador documented five patients who developed telogen effluvium or more extensive hair loss between 3 and 17 days after receiving a booster dose of a mixed vaccine regimen.21PubMed Central. A Case Series and Literature Review of Telogen Effluvium and Alopecia Universalis after the Administration of a Heterologous COVID-19 Vaccine Scheme Five cases are not enough to establish a strong link, but they do show that the immune activation triggered by vaccination can, in rare instances, push hair follicles into telogen. The scale of this problem is far smaller than what is seen after actual COVID-19 infection. If you noticed some extra shedding after a vaccine dose, it almost certainly resolved on its own.
When Shedding Might Be Something Else
Telogen effluvium is the most common hair-related consequence of COVID-19, but it is not the only one. Alopecia areata, an autoimmune condition that causes patchy bald spots rather than diffuse thinning, has also been linked to COVID-19 infection. A large population-based analysis published in JAMA Dermatology found evidence supporting a possible role for COVID-19 in triggering or worsening alopecia areata, with proposed mechanisms including molecular mimicry between viral proteins and hair follicle proteins, as well as broader immune dysregulation.22JAMA Dermatology. Risk of Alopecia Areata After COVID-19 – Section: Discussion
The practical distinction matters because treatment approaches differ. Telogen effluvium involves diffuse, all-over thinning and is self-limiting. Alopecia areata involves well-defined patches and may require immunosuppressive therapy. If you are seeing smooth, coin-shaped bald patches rather than generalized thinning, or if the shedding is concentrated in distinct areas, a dermatologist can help distinguish between the two. Some patients may even experience both simultaneously, since the immune disruption from COVID-19 can trigger multiple hair-related conditions.
What Actually Helps Recovery
The honest answer for most people with post-COVID telogen effluvium is that time is the primary treatment. Once the triggering event has passed and the body has recovered from the infection, the follicles re-enter the growth phase on their own. New hair growth typically becomes visible within three to six months after the shedding peaks, though it can take up to a year for hair density to feel fully restored.
That said, there are several things that can support the process or prevent it from dragging on longer than necessary:
- Check ferritin levels: Given the association between low ferritin and post-COVID shedding, a blood test is worthwhile. If levels are low, iron supplementation can help the follicles recover more efficiently.
- Maintain adequate nutrition: Ensuring sufficient intake of vitamin D, zinc, and protein supports the hair cycle. Post-COVID fatigue and reduced appetite can make nutritional deficiencies worse, so paying attention to diet during recovery matters.
- Manage stress actively: Because psychological distress can perpetuate the shedding cycle, finding effective ways to manage anxiety about the hair loss itself can make a real difference.
- Avoid aggressive styling: Tight hairstyles, excessive heat, and chemical treatments put mechanical stress on already vulnerable follicles. Gentler handling during the shedding phase reduces breakage and the appearance of thinning.
For persistent cases lasting beyond six months, dermatologists may consider topical treatments like minoxidil, which can help stimulate regrowth and shorten the telogen phase. Platelet-rich plasma injections and growth factor formulations have also been explored in small clinical studies.23PubMed. Efficacy of QR678 Neo(®) hair growth factor formulation for the treatment of hair loss in Covid-19-induced persistent Telogen Effluvium These interventions are typically reserved for cases that have not resolved on their own within the expected timeframe.
Other Hair Changes After COVID-19
Hair loss gets the most attention, but it is not the only change people notice after COVID-19. The same cross-sectional study that found telogen effluvium in about 61 percent of surveyed women also documented increased gray hair in about 14 percent, seborrheic dermatitis in about 6 percent, and trichotillomania (stress-related hair pulling) in nearly 4 percent.24PubMed Central. Hair disorders associated with post-COVID-19 infection in females – Section: Results The graying is likely related to oxidative stress on melanocyte stem cells in the follicle, and it can be permanent. Seborrheic dermatitis, which causes flaking and scalp irritation, may be driven by the same immune dysregulation that promotes the hair shedding itself.
Healthcare workers appear to have been especially affected by hair problems during the pandemic, though disentangling the direct effects of infection from the chronic occupational stress, mask wearing, and repeated exposure is difficult.25PubMed Central. The Effect of Covid-19 on the Hair Diseases Observed in Health Care Providers: Analysis of 513 Participants The broader point is that COVID-19 affects the hair in ways that go beyond simple shedding, and the combination of systemic inflammation, immune disruption, and prolonged psychological stress creates a perfect storm for the scalp.